This is a Validated Antibody Database (VAD) review about Rhesus mon.. CD14, based on 48 published articles (read how Labome selects the articles), using CD14 antibody in all methods. It is aimed to help Labome visitors find the most suited CD14 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD14 synonym: monocyte differentiation antigen CD14

BioLegend
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:200; loading ...; fig 1b
BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples at 1:200 (fig 1b). Front Immunol (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1c
BioLegend CD14 antibody (BioLegend, 301824) was used in flow cytometry on human samples (fig 1c). J Exp Med (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD14 antibody (Biolegend, 301802) was used in flow cytometry on human samples (fig 1a). Cell (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig s1). J Clin Invest (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 2c
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig 2c). Nat Immunol (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig s1). J Biol Chem (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 6a
BioLegend CD14 antibody (Biolegend, 301818) was used in flow cytometry on human samples (fig 6a). Front Immunol (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1c
In order to study the involvement of RANKL in decidual M2 macrophage polarization, BioLegend CD14 antibody (Biolegend, 301804) was used in flow cytometry on human samples (fig 1c). Cell Death Dis (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; African green monkey; loading ...; fig 2a
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on African green monkey samples (fig 2a). Immunology (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 5a
In order to study the involvement of Notch signaling in NK cell lineage determination, BioLegend CD14 antibody (biolegend, M5E2) was used in flow cytometry on human samples (fig 5a). J Immunol (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s4a
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig s4a). J Immunol (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 6b
BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples (fig 6b). PLoS ONE (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig 1a). Sci Rep (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 7a
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig 7a). Leuk Lymphoma (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...
In order to investigate the effectiveness of a neoantigen vaccine against melanoma, BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples . Nature (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 7c
In order to study the role of leukocyte antigen F in and antigen presentation and immune response, BioLegend CD14 antibody (BioLegend, 301811) was used in flow cytometry on human samples (fig 7c). Immunity (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:50; loading ...; fig s2b
In order to define the transcriptional network specifies conferring microglia identity, BioLegend CD14 antibody (BioLegend, 301811) was used in flow cytometry on human samples at 1:50 (fig s2b). Science (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 3g
In order to map the lineage of human dendritic cells, BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig 3g). Science (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s3f
In order to report that autosomal recessive, partial Go-Ichi-Ni-San 1 deficiency impairs DNA replication and underlies intra-uterine and postnatal growth retardation, chronic neutropenia, and natural killer cell deficiency, BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig s3f). J Clin Invest (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...
In order to examine AnxA1 in peripheral blood mononuclear cells from patients with coronary artery disease, BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples . PLoS ONE (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; tbl s9
In order to optimize and assess potential malaria vaccine regimens, BioLegend CD14 antibody (BioLegend, 301842) was used in flow cytometry on human samples (tbl s9). Nature (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; Rhesus monkey; loading ...
In order to examine the kinetics of SIV-specific CD8+ T cell cytolytic factor expression in peripheral blood, lymph node, spleen, and gut mucosa from early acute infection through chronic infection, BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on Rhesus monkey samples . PLoS Pathog (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD14 antibody (BioLegend, 301842) was used in flow cytometry on human samples (fig 4a). PLoS ONE (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; mouse; loading ...; fig s4
In order to study the impact of modulating IFN-I signaling during suppressive combined antiretroviral therapy, BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on mouse samples (fig s4). J Clin Invest (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s4
BioLegend CD14 antibody (Biologend, M5E2) was used in flow cytometry on human samples (fig s4). Cell Death Dis (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 2
In order to identify cells that respond to interferon lambda, BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples (fig 2). J Interferon Cytokine Res (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD14 antibody (BioLegend, 301804) was used in flow cytometry on human samples (fig 2a). Oncogene (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...
In order to study the cytolytic effector capacity of HIV-specific CD8+ T cells, BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples . PLoS Pathog (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples (fig 1a). PLoS ONE (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD14 antibody (BioLegend, 301804) was used in flow cytometry on human samples (fig 2a). Oncotarget (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; Rhesus monkey; loading ...
In order to optimize vaccination with Aventis Pasteur's canarypox vector-HIV, BioLegend CD14 antibody (BioLegend, 301842) was used in flow cytometry on Rhesus monkey samples . Nat Med (2016) ncbi
mouse monoclonal (M5E2)
  • mass cytometry; human; loading ...; tbl 1, 2
In order to use elemental metal isotopes conjugated to monoclonal antibodies and study intracellular functional markers and surface phenotypic markers on natural killer cells, BioLegend CD14 antibody (Biolegend, M5E2) was used in mass cytometry on human samples (tbl 1, 2). Methods Mol Biol (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1b
In order to develop a method to detect circulating B cells that recognize nuclear antigens in patients, BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig 1b). Arthritis Rheumatol (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 2
BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples (fig 2). J Virol (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
In order to identify the cell surface markers in synovial mesenchymal stem cells, BioLegend CD14 antibody (Biolegend, 301808) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BioLegend CD14 antibody (Biolegend, 301808) was used in flow cytometry on human samples . Thromb Res (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; mouse
In order to compare the initial systemic Env-specific B cell responses of AGMs and rhesus macaques, BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on mouse samples . J Virol (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig s5
In order to identify the response to anti-MPO antibodies in the form of increased surface expression of ANCA autoantigens and IL-1beta secretion acting as intermediate monocytes in ANCA vasculitis, BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples (fig s5). Sci Rep (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig S2
In order to look at patterns of S. Typhi-specific modulation of the homing potential of circulating Treg in patients with typhoid compared to healthy individuals, BioLegend CD14 antibody (biolegend, 301831) was used in flow cytometry on human samples (fig S2). PLoS Pathog (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:100; fig 3
BioLegend CD14 antibody (Biolegend, 301814) was used in flow cytometry on human samples at 1:100 (fig 3). Nat Commun (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BioLegend CD14 antibody (Biolegend, 301820) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 1
BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples (fig 1). J Infect Dis (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples . Immun Inflamm Dis (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; Rhesus monkey
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on Rhesus monkey samples . J Infect Dis (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig S1
  • immunocytochemistry; human
In order to discuss blood gammadeltaT subsets and their potential role in cancer immunotherapy, BioLegend CD14 antibody (BioLegend, 301806) was used in flow cytometry on human samples (fig S1) and in immunocytochemistry on human samples . Clin Cancer Res (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1
In order to test if hip fracture and depressive symptoms had additive effects upon the aged immune system, BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig 1). Exp Gerontol (2014) ncbi
Articles Reviewed
  1. Jones G, Bain C, Fenton T, Kelly A, Brown S, Ivens A, et al. Dynamics of Colon Monocyte and Macrophage Activation During Colitis. Front Immunol. 2018;9:2764 pubmed publisher
  2. Kelly A, Günaltay S, McEntee C, Shuttleworth E, Smedley C, Houston S, et al. Human monocytes and macrophages regulate immune tolerance via integrin αvβ8-mediated TGFβ activation. J Exp Med. 2018;215:2725-2736 pubmed publisher
  3. Olin A, Henckel E, Chen Y, Lakshmikanth T, Pou C, Mikes J, et al. Stereotypic Immune System Development in Newborn Children. Cell. 2018;174:1277-1292.e14 pubmed publisher
  4. Risnes L, Christophersen A, Dahal Koirala S, Neumann R, Sandve G, Sarna V, et al. Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease. J Clin Invest. 2018;128:2642-2650 pubmed publisher
  5. Clayton K, Collins D, Lengieza J, Ghebremichael M, Dotiwala F, Lieberman J, et al. Resistance of HIV-infected macrophages to CD8+ T lymphocyte-mediated killing drives activation of the immune system. Nat Immunol. 2018;19:475-486 pubmed publisher
  6. Melo Gonzalez F, Fenton T, Forss C, Smedley C, Goenka A, MacDonald A, et al. Intestinal mucin activates human dendritic cells and IL-8 production in a glycan-specific manner. J Biol Chem. 2018;293:8543-8553 pubmed publisher
  7. Nieto C, Bragado R, Municio C, Sierra Filardi E, Alonso B, Escribese M, et al. The Activin A-Peroxisome Proliferator-Activated Receptor Gamma Axis Contributes to the Transcriptome of GM-CSF-Conditioned Human Macrophages. Front Immunol. 2018;9:31 pubmed publisher
  8. Meng Y, Zhou W, Jin L, Liu L, Chang K, Mei J, et al. RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization. Cell Death Dis. 2017;8:e3105 pubmed publisher
  9. Holbrook B, Aycock S, Machiele E, Clemens E, Gries D, Jorgensen M, et al. An R848 adjuvanted influenza vaccine promotes early activation of B cells in the draining lymph nodes of non-human primate neonates. Immunology. 2018;153:357-367 pubmed publisher
  10. Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Hayashi T, Nakachi K, et al. Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors. J Immunol. 2017;199:2777-2793 pubmed publisher
  11. Salio M, Gasser O, González López C, Martens A, Veerapen N, Gileadi U, et al. Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells. J Immunol. 2017;199:2631-2638 pubmed publisher
  12. Lee J, Tam H, Adler L, Ilstad Minnihan A, Macaubas C, Mellins E. The MHC class II antigen presentation pathway in human monocytes differs by subset and is regulated by cytokines. PLoS ONE. 2017;12:e0183594 pubmed publisher
  13. Lunemann S, Martrus G, Goebels H, Kautz T, Langeneckert A, Salzberger W, et al. Hobit expression by a subset of human liver-resident CD56bright Natural Killer cells. Sci Rep. 2017;7:6676 pubmed publisher
  14. Ichii M, Oritani K, Murase M, Komatsu K, Yamazaki M, Kyoden R, et al. Molecular targeting of inosine-5'-monophosphate dehydrogenase by FF-10501 promotes erythropoiesis via ROS/MAPK pathway. Leuk Lymphoma. 2018;59:448-459 pubmed publisher
  15. Ott P, Hu Z, Keskin D, Shukla S, Sun J, Bozym D, et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature. 2017;547:217-221 pubmed publisher
  16. Dulberger C, McMurtrey C, Hölzemer A, Neu K, Liu V, Steinbach A, et al. Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors. Immunity. 2017;46:1018-1029.e7 pubmed publisher
  17. Gosselin D, Skola D, Coufal N, Holtman I, Schlachetzki J, Sajti E, et al. An environment-dependent transcriptional network specifies human microglia identity. Science. 2017;356: pubmed publisher
  18. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed publisher
  19. Cottineau J, Kottemann M, Lach F, Kang Y, Vély F, Deenick E, et al. Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest. 2017;127:1991-2006 pubmed publisher
  20. Bergström I, Lundberg A, Jonsson S, Särndahl E, Ernerudh J, Jonasson L. Annexin A1 in blood mononuclear cells from patients with coronary artery disease: Its association with inflammatory status and glucocorticoid sensitivity. PLoS ONE. 2017;12:e0174177 pubmed publisher
  21. Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka A, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445-449 pubmed publisher
  22. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed publisher
  23. Roberts E, Carnathan D, Li H, Shaw G, Silvestri G, Betts M. Collapse of Cytolytic Potential in SIV-Specific CD8+ T Cells Following Acute SIV Infection in Rhesus Macaques. PLoS Pathog. 2016;12:e1006135 pubmed publisher
  24. Assadi G, Vesterlund L, Bonfiglio F, Mazzurana L, Cordeddu L, Schepis D, et al. Functional Analyses of the Crohn's Disease Risk Gene LACC1. PLoS ONE. 2016;11:e0168276 pubmed publisher
  25. Cheng L, Ma J, Li J, Li D, Li G, Li F, et al. Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs. J Clin Invest. 2017;127:269-279 pubmed publisher
  26. Andresen V, Erikstein B, Mukherjee H, Sulen A, Popa M, Sørnes S, et al. Anti-proliferative activity of the NPM1 interacting natural product avrainvillamide in acute myeloid leukemia. Cell Death Dis. 2016;7:e2497 pubmed publisher
  27. Kelly A, Robinson M, Roche G, Biron C, O Farrelly C, Ryan E. Immune Cell Profiling of IFN-? Response Shows pDCs Express Highest Level of IFN-?R1 and Are Directly Responsive via the JAK-STAT Pathway. J Interferon Cytokine Res. 2016;36:671-680 pubmed
  28. Deng Y, Cheng J, Fu B, Liu W, Chen G, Zhang Q, et al. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells. Oncogene. 2017;36:1090-1101 pubmed publisher
  29. Demers K, Makedonas G, Buggert M, Eller M, Ratcliffe S, Goonetilleke N, et al. Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection. PLoS Pathog. 2016;12:e1005805 pubmed publisher
  30. Gadd V, Patel P, Jose S, Horsfall L, Powell E, Irvine K. Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation. PLoS ONE. 2016;11:e0157771 pubmed publisher
  31. Zhang G, Liu H, Huang J, Chen S, Pan X, Huang H, et al. TREM-1low is a novel characteristic for tumor-associated macrophages in lung cancer. Oncotarget. 2016;7:40508-40517 pubmed publisher
  32. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed publisher
  33. Kay A, Strauss Albee D, Blish C. Application of Mass Cytometry (CyTOF) for Functional and Phenotypic Analysis of Natural Killer Cells. Methods Mol Biol. 2016;1441:13-26 pubmed publisher
  34. Malkiel S, Jeganathan V, Wolfson S, Manjarrez Orduno N, Marasco E, Aranow C, et al. Checkpoints for Autoreactive B Cells in the Peripheral Blood of Lupus Patients Assessed by Flow Cytometry. Arthritis Rheumatol. 2016;68:2210-20 pubmed publisher
  35. Offersen R, Nissen S, Rasmussen T, Østergaard L, Denton P, Søgaard O, et al. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells. J Virol. 2016;90:4441-4453 pubmed publisher
  36. Denkovskij J, Rudys R, Bernotiene E, Minderis M, Bagdonas S, Kirdaite G. Cell surface markers and exogenously induced PpIX in synovial mesenchymal stem cells. Cytometry A. 2015;87:1001-11 pubmed publisher
  37. Granja T, Schad J, Schüssel P, Fischer C, Häberle H, Rosenberger P, et al. Using six-colour flow cytometry to analyse the activation and interaction of platelets and leukocytes--A new assay suitable for bench and bedside conditions. Thromb Res. 2015;136:786-96 pubmed publisher
  38. Amos J, Himes J, Armand L, Gurley T, Martinez D, Colvin L, et al. Rapid Development of gp120-Focused Neutralizing B Cell Responses during Acute Simian Immunodeficiency Virus Infection of African Green Monkeys. J Virol. 2015;89:9485-98 pubmed publisher
  39. O Brien E, Abdulahad W, Rutgers A, Huitema M, O Reilly V, Coughlan A, et al. Intermediate monocytes in ANCA vasculitis: increased surface expression of ANCA autoantigens and IL-1β secretion in response to anti-MPO antibodies. Sci Rep. 2015;5:11888 pubmed publisher
  40. McArthur M, Fresnay S, Magder L, Darton T, Jones C, Waddington C, et al. Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model. PLoS Pathog. 2015;11:e1004914 pubmed publisher
  41. Xue J, Sharma V, Hsieh M, Chawla A, Murali R, Pandol S, et al. Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis. Nat Commun. 2015;6:7158 pubmed publisher
  42. Inglis H, Danesh A, Shah A, Lacroix J, Spinella P, Norris P. Techniques to improve detection and analysis of extracellular vesicles using flow cytometry. Cytometry A. 2015;87:1052-63 pubmed publisher
  43. Boyle M, Jagannathan P, Bowen K, McIntyre T, Vance H, Farrington L, et al. Effector Phenotype of Plasmodium falciparum-Specific CD4+ T Cells Is Influenced by Both Age and Transmission Intensity in Naturally Exposed Populations. J Infect Dis. 2015;212:416-25 pubmed publisher
  44. Heninger A, Wentrup S, Al Saeedi M, Schiessling S, Giese T, Wartha F, et al. Immunomodulation of human intestinal T cells by the synthetic CD80 antagonist RhuDex®. Immun Inflamm Dis. 2014;2:166-80 pubmed publisher
  45. Li H, Evans T, Gillis J, Connole M, Reeves R. Bone marrow-imprinted gut-homing of plasmacytoid dendritic cells (pDCs) in acute simian immunodeficiency virus infection results in massive accumulation of hyperfunctional CD4+ pDCs in the mucosae. J Infect Dis. 2015;211:1717-25 pubmed publisher
  46. Tungatt K, Bianchi V, Crowther M, Powell W, Schauenburg A, Trimby A, et al. Antibody stabilization of peptide-MHC multimers reveals functional T cells bearing extremely low-affinity TCRs. J Immunol. 2015;194:463-74 pubmed publisher
  47. Fisher J, Yan M, Heuijerjans J, Carter L, Abolhassani A, Frosch J, et al. Neuroblastoma killing properties of Vδ2 and Vδ2-negative γδT cells following expansion by artificial antigen-presenting cells. Clin Cancer Res. 2014;20:5720-32 pubmed publisher
  48. Duggal N, Beswetherick A, Upton J, Hampson P, Phillips A, Lord J. Depressive symptoms in hip fracture patients are associated with reduced monocyte superoxide production. Exp Gerontol. 2014;54:27-34 pubmed publisher